EUPRAXIA PHARMACEUTICALS INC

Historical 13F Holders

Symbol
EPRX
CUSIP
29842P105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29842P105 since 12/18/2024, largest first.

Filer % of Class Filed
Joseph S. Freedman 13D/A 9.0% 3/16/2026
Event 3/13/2026
Beutel, Goodman & Co Ltd. 13G 8.0% 11/14/2025
Event 9/30/2025
Robert Disbrow 13G/A 7.0% 11/14/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Manchester Management Co LLC 13G/A
4.5% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 79.7 k $561 k
2026 Q2 67 24.8 M $164 M
2026 Q1 55 22.2 M $158 M
2025 Q4 36 13.9 M $105 M
2025 Q3 28 12.8 M $75.4 M
2025 Q2 16 2.40 M $13.4 M
2025 Q1 12 2.17 M $7.09 M
2024 Q4 10 1.83 M $5.63 M
2024 Q3 9 1.80 M $4.55 M
2024 Q2 10 1.73 M $4.44 M